![]() |
市场调查报告书
商品编码
1865403
全球微生物组检测和个人化护肤市场:预测至2032年-按产品类型、成分类型、客製化方法、皮肤类型、皮肤状况、样本类型、最终用户、分销管道和地区进行分析Microbiome Testing & Personalized Skincare Market Forecasts to 2032 - Global Analysis By Product Type, Ingredient Type, Customization Method, Skin Type Focus, Skin Condition, Sample Type, End User, Distribution Channel, and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球微生物组测试和个人化护肤市场价值将达到 4.893 亿美元,到 2032 年将达到 11.161 亿美元。
预计在预测期内,该领域将以12.5%的复合年增长率成长。护肤微生物组检测是指分析个别皮肤微生物组,以识别其独特的微生物组成。这些数据用于提供个人化的护肤方案,以支持和平衡皮肤的天然生态系统。个人化护肤利用这些洞察,提案针对特定皮肤问题(例如敏感、痤疮或皮肤干燥)的产品和疗程。透过根据微生物组特征定製配方,这种方法可以提高功效并促进皮肤健康,代表着精准皮肤病学和个人化健康策略的转变。
皮肤疾病发生率上升与微生物群失衡有关。
与微生物群过度生长相关的皮肤疾病,例如痤疮、湿疹和酒糟,日益增多,推动了消费者对针对性护肤解决方案的需求。消费者寻求能够恢復微生物平衡的产品,促使各大品牌加大对微生物组检测和个人化配方研发的投入。人们对皮肤健康和有益菌作用的认识不断提高,进一步推动了这一趋势。随着临床研究证实这些关联,皮肤科医生和健康专家的兴趣日益浓厚,加速了整个护肤行业的创新和应用。
关于基因和微生物组资讯的资料隐私问题
消费者越来越谨慎地对待共用生物讯息,尤其是在直接面向消费者的测试模式下。监管审查的加强和缺乏标准化的资料保护框架进一步阻碍了此类服务的普及。企业必须在确保透明度和获得用户同意的同时,努力遵守GDPR和HIPAA等法规。这些隐私方面的挑战可能会减缓消费者接受此类服务的速度,并限制个人化护肤平台的扩充性,尤其是在资料管治政策严格的地区。
拓展男士护肤市场
传统上被忽视的男士护肤市场正面临着日益增长的需求,消费者希望找到能够解决特定肌肤问题的产品,例如剃须刺激、控油和老龄化。各大品牌正利用微生物组学的研究成果,发展针对不同性别的配方和行销策略。此外,电子商务的兴起和网红影响力的提升,也帮助男士养成护肤习惯,为该领域的产品多元化和市场拓展创造了机会。
与现有护肤品牌的竞争
拥有稳固市场基础和忠实基本客群的成熟护肤品牌对专注于微生物组的新兴企业构成竞争威胁。这些老牌企业拥有广泛的分销网络、规模经济和品牌信誉等优势,使得新进业者难以立足市场。此外,传统品牌正越来越多地将有益于微生物组的宣传融入现有产品线,模糊了产品差异化。缺乏明确的科学检验和消费者教育,个人化微生物组解决方案容易被淹没在传统产品之中,从而延缓市场渗透和品牌认知度的提升。
新冠疫情对微生物组护肤市场产生了复杂的影响。虽然供应链中断和商店销售额下降最初阻碍了市场成长,但网路购物和自我护理习惯的兴起创造了新的机会。消费者健康意识的增强推动了对个人化、实证护肤的兴趣。此外,远距咨询和数位化平台也使得微生物组检测服务得以持续进行。疫情加速了向电子商务和健康导向消费的转变,最终凸显了个人化护肤在后疫情时代消费行为的重要性。
预计在预测期内,外用药物细分市场将占据最大的市场份额。
由于其易用性和消费者熟悉度,预计外用製剂将在预测期内占据最大的市场份额。这些产品直接作用于皮肤微生物群,使其成为开发个人化配方的理想选择。此外,外用给药系统可灵活添加益生元、益生菌和后生元,进而增强功效。较高的零售认知度和与现有护肤流程的亲和性正在推动该领域的广泛应用。在技术不断创新的背景下,外用製剂仍将是基于微生物群的护肤解决方案的基础。
预计在预测期内,后生元细分市场将呈现最高的复合年增长率。
由于其稳定性、安全性和已证实的护肤功效,预计后生元领域在预测期内将实现最高成长率。与活性益生菌不同,后生元由细菌代谢产物和细胞碎片组成,易于配製和储存,因此对生产者极具吸引力。此外,后生元在临床研究和研发领域正日益受到关注,进一步提升了其可信度。随着监管政策的明朗化和公众意识的不断提高,预计该领域将在高端市场和大众市场均实现快速成长。
预计在整个预测期内,北美将占据最大的市场份额,这得益于其先进的皮肤病学基础设施、较高的消费者意识以及生物技术Start-Ups的强大实力。尤其是在美国,个人化护肤的普及速度很快,这主要得益于其强大的电子商务管道和日益增长的健康意识。监管机构对创新的支持以及越来越多的健康意识消费者进一步巩固了该地区的优势。护肤品牌与研究机构之间的策略合作也有助于提升产品的可信度。
预计亚太地区在预测期内将实现最高的复合年增长率,这主要得益于可支配收入的增长、美容意识的提高以及对个性化解决方案需求的不断增长。韩国、日本和中国等国家在护肤创新方面处于领先地位,消费者对注重微生物群的产品趋之若鹋。该地区整体健康理念和对天然成分的文化重视与基于微生物群的配方完美契合。此外,数位平台和网红行销的兴起也加速了产品认知度的提升。
According to Stratistics MRC, the Global Microbiome Testing & Personalized Skincare Market is accounted for $489.3 million in 2025 and is expected to reach $1,116.1 million by 2032, growing at a CAGR of 12.5% during the forecast period. Microbiome testing in skincare involves analyzing an individual's skin microbiota to identify the unique composition of microorganisms present. This data informs personalized skincare solutions tailored to support and balance the skin's natural ecosystem. Personalized skincare leverages these insights to recommend targeted products and routines that address specific skin concerns, such as sensitivity, acne, or dryness. By aligning formulations with microbiome profiles, this approach enhances efficacy, promotes skin health, and represents a shift toward precision dermatology and individualized wellness strategies.
Rising prevalence of skin conditions linked to microbiome imbalance
The increasing incidence of skin disorders such as acne, eczema, and rosacea often associated with microbiome dysbiosis is driving demand for targeted skincare solutions. Consumers are seeking products that restore microbial balance, prompting brands to invest in microbiome testing and personalized formulations. This trend is further supported by growing awareness of skin health and the role of beneficial bacteria. As clinical research validates these links, the market is witnessing heightened interest from dermatologists and wellness professionals, thereby accelerating innovation and adoption across skincare categories.
Data privacy concerns regarding genetic and microbiome information
Consumers are increasingly cautious about sharing biological information, especially in direct-to-consumer testing models. Regulatory scrutiny and lack of standardized data protection frameworks further complicate adoption. Companies must navigate compliance with GDPR and HIPAA while ensuring transparency and consent. These privacy challenges may slow down consumer onboarding and limit the scalability of personalized skincare platforms, particularly in regions with stringent data governance policies.
Expansion into men's skincare
Traditionally underserved, the men's skincare segment is now witnessing increased demand for targeted solutions addressing issues like shaving irritation, oil control, and aging. Brands are leveraging microbiome insights to develop gender-specific formulations and marketing strategies. Moreover, the rise of e-commerce and influencer-driven awareness is helping normalize skincare routines among men, creating a fertile ground for product diversification and market expansion in this demographic.
Competition from traditional skincare brands
Established skincare brands with strong market presence and loyal customer bases pose a competitive threat to microbiome-focused startups. These incumbents often benefit from extensive distribution networks, economies of scale, and brand trust, making it challenging for newer entrants to gain traction. Additionally, traditional brands are increasingly incorporating microbiome-friendly claims into their existing product lines, blurring differentiation. Without clear scientific validation and consumer education, personalized microbiome solutions risk being overshadowed by conventional offerings, potentially slowing market penetration and brand recognition.
The COVID-19 pandemic had a mixed impact on the microbiome skincare market. While supply chain disruptions and reduced in-store purchases initially hindered growth, the surge in online shopping and self-care routines created new opportunities. Consumers became more health-conscious, driving interest in personalized and science-backed skincare. Moreover, remote consultations and digital platforms enabled continued engagement with microbiome testing services. The pandemic accelerated the shift toward e-commerce and wellness-driven consumption, ultimately reinforcing the relevance of personalized skincare in post-pandemic consumer behavior.
The topical formats segment is expected to be the largest during the forecast period
The topical formats segment is expected to account for the largest market share during the forecast period due to their ease of application and consumer familiarity. These products allow for direct interaction with the skin's microbiota, making them ideal for personalized formulations. Additionally, topical delivery systems offer flexibility in incorporating prebiotics, probiotics, and postbiotics, enhancing efficacy. The segment benefits from strong retail visibility and compatibility with existing skincare routines, which supports widespread adoption. As innovation continues, topical formats remain the cornerstone of microbiome-based skincare solutions.
The postbiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the postbiotics segment is predicted to witness the highest growth rate owing to their stability, safety, and proven skin benefits. Unlike live probiotics, postbiotics comprising bacterial metabolites and cell fragments are easier to formulate and store, making them attractive for manufacturers. Furthermore, postbiotics are gaining traction in clinical research and product development, reinforcing their credibility. As regulatory clarity improves and awareness grows, this segment is poised for rapid expansion across both premium and mass-market offerings.
During the forecast period, the North America region is expected to hold the largest market share propelled by its advanced dermatological infrastructure, high consumer awareness, and strong presence of biotech startups. The U.S. in particular has seen early adoption of personalized skincare, supported by robust e-commerce channels and wellness trends. Regulatory support for innovation and a growing base of health-conscious consumers further contribute to regional dominance. Strategic collaborations between skincare brands and research institutions also enhance product credibility.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising disposable incomes, expanding beauty consciousness, and increasing demand for personalized solutions. Countries like South Korea, Japan, and China are at the forefront of skincare innovation, with consumers embracing microbiome-friendly products. The region's cultural emphasis on holistic wellness and natural ingredients aligns well with microbiome-based formulations. Moreover, the proliferation of digital platforms and influencer marketing is accelerating product awareness.
Key players in the market
Some of the key players in Microbiome Testing & Personalized Skincare Market include Viome Life Sciences, Inc., DayTwo Inc., ZOE Limited, Pendulum Therapeutics, Inc., Microba Life Sciences Pty Ltd, Atlas Biomed Group Ltd, Sun Genomics, Inc., Microbiome Insights, Inc., CosmosID, Inc., Givaudan SA, Unilever PLC, L'Oreal S.A., Parallel Health, Inc., Azitra, Inc., Eligo Bioscience SA, and Codex Labs UK Limited.
In July 2025, Viome partnered with Microsoft to scale its RNA-based health platform using AI and cloud computing, offering at-home testing kits analyzing saliva, blood, and stool samples for personalized diet, supplements, and oral care products including a personalized oral microbiome toothpaste "MyBiotics.
In June 2025, Viome acquired digital health company Naring Health to enhance personalized nutrition and longevity solutions, combining clinical data and food-genetic insights.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.